Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Eosinophilic Disorders
•
Primary Care
How long would you treat severe eosinophilic asthma/pneumonia with q4week anti-IL5 therapy prior to tapering?
Related Questions
Would you ever use dupilumab for atopic dermatitis in a patient who also has EGPA?
What treatment approach do you suggests for a patient with nasal polyp disease and asthma who was improved on dupilumab, but over last 2 years has begun to have increased nasal symptoms and rising eosinophil counts?
How often do you monitor the eosinophil count after initiating anti-IL5 therapy for HAE?
Does splitting the dose of a vaccine during an observed administration affect the efficacy of the vaccine response?
Do you continue to check tryptase levels in your patients with idiopathic anaphylaxis despite normal levels >5 on repeated checks?
Does food sensitivity testing for IgG subclasses help guide your management of food allergy?
Does a diagnosis of NARES change your management of rhinitis?
What are your recommendations for managing perivascular dermatitis with eosinophils unresponsive to high-dose antihistamines, a prednisone taper, and topical steroids?
Do you avoid use of inhalers with milk protein in patients with a milk allergy?
How do you manage introduction of other seeds when the patient has never been exposed and has a sesame allergy?
